Investing.comDoubao · 实盘不做把握 6/10不做原因:风险收益比不佳
北京时间·🕒 发布 19:10:59·⟳ 抓取 19:14:17 +3m18s·⚡ 决策 10-14 19:16:38 +2m21s·13.4 天前
Sono-Tek（SOTK）Q2 FY2027 财报EPS与营收双低于预期，盘前一度跌约14.5%，但医疗高增、backlog与新单强劲、全年指引维持
财报双miss方向偏空，但幅度小且被强前瞻指标（backlog环比+23%、季末后$7.19M新单、医疗+209%、毛利率扩张、指引维持）大幅对冲，不构成需求/指引恶化的强空催化；同时SOTK为约1.12亿美元纳米盘、日均成交额不足90万美元、盘前极薄量、买卖价差宽，且近20日急涨58%，此时做空风险回报差，利空亦不反手做多。
📄 原文Investing.com↗ 原文
Sono-Tek stock falls 14% on second quarter earnings, revenue miss
ASML shares climb on raised 2026 outlook, capacity expansion plans MILTON, N.Y. -On Wednesday, Sono-Tek Corporation (NA…
不做 Sono-Tek Corporation（SOTK.US）
财报小幅双miss但系订单时点、backlog与$7.19M新单强劲且指引维持，强空催化不足；纳米盘流动性极差、盘前已-14.5%、近20日+58%逼空与价差风险高，利空不反手做多，多空均无正期望。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
Sono-Tek Q2 EPS与营收小幅双miss致盘前跌约14.5%，但系大订单时点、backlog与新单强劲且全年指引维持，净基本面损害有限；叠加纳米盘极差流动性与急涨后逼空风险，多空均无正期望，回避。
🔎 新鲜度:最早出现 2026-10-14 · 扩散 low · price-in 风险 medium ↗
关键理由
- 做空：财报双miss且盘前-14.5%，但仅为时点性、净利绝对额很小（$366K），指引未下调，强空逻辑不成立。
- 做多：医疗+209%、backlog环比+23%、季末后$7.19M新单（FY2028）与毛利率扩张提供基本面支撑，但负面财报事件不构成本框架做多触发。
主要风险
- 纳米盘流动性极差（日均成交额不足90万美元、盘前约2,905股、买卖价差6.10/6.34），开盘可能跳空放大、止损难以可靠执行。
- 近20日股价+58%、位于52周高位附近，做空存在空头回补逼空风险；若市场聚焦backlog与新单，跌幅可能快速收敛。
反向证据
- 做空前查反向 · 来源 web · 日期 2026-10-14 · 影响 weakens
反向证据强：backlog环比+23%至$9.51M、季末后新增$7.19M订单、医疗+209%、毛利率53%、维持全年指引，miss被定性为订单时点而非需求恶化。
检索:Sono-Tek Q2 FY2027 backlog orders guidance medical demand 原文 ↗
先例如何影响了这次决策
对本次决策的影响:结论由净基本面（弱miss+强backlog/维持指引）与流动性/逼空风险决定，而非先例；无先例进一步支持回避。
方向:无可引用先例；纳米盘miss后的方向高度依赖订单时点解释与流动性，不据此外推。
涨幅量级:缺乏同市场同相位高相似首发先例，不用以校准tp/sl。
形态:无足够样本判断见光死或超跌反弹模式。
工具执行结果 · 成功 2 · 降级 0 · 失败 0 · 取消 0
- search_processed_events 成功 stock_tools HTTP · 12 ms
{"result": "search_processed_events:agent query=`sono-tek backlog $7.19 million orders medical coating | sono-tek q2 fy2027 eps $0.02 revenue $5.23 million premarket drop | sono-tek sotk second quarter fiscal 2027 earnings revenu`；结构化索引覆盖完整 72 小时；旧记录兼容扫描近 0.0/72 小时、0 条本臂决策(完整)，返回 0 条候选。未命中只表示这些 agen - stock_quote 成功 stock_tools HTTP · 1,125 ms
{
原文全文
展开原文 · 2,208 字
ASML shares climb on raised 2026 outlook, capacity expansion plans
MILTON, N.Y. -On Wednesday, Sono-Tek Corporation (NASDAQ:SOTK) reported second quarter fiscal 2027 results that fell short of analyst expectations, with both earnings and revenue missing consensus estimates as the company navigates the timing of large production system orders.
Shares of the precision ultrasonic coating systems manufacturer fell 14.47% in pre-market trading following the results.
The company posted adjusted earnings per share of $0.02, missing the analyst consensus of $0.04 by $0.02. Revenue for the quarter ended August 31, 2026, came in at $5.23 million, below the $5.56 million consensus estimate, though up 1% YoY from $5.16 million in the prior-year period.
Despite the quarterly miss, Sono-Tek reported strong performance in its medical sector, with sales surging 209% to $3.11 million in the second quarter, driven by shipments of balloon coating systems and specialty stent-coating systems.
For the first half of fiscal 2027, revenue increased 6% to $10.89 million, with medical market sales jumping 289% to $7.05 million.
Gross margin expanded to 53% in the second quarter from 50% in the prior-year period, reflecting what the company described as an unusually favorable product and geographic mix.
Operating income decreased 9% to $382,000, while net income declined 14% to $366,000, or $0.02 per diluted share, compared with $424,000, or $0.03 per diluted share, in the second quarter of fiscal 2026.
"Fiscal 2027 is progressing well, with solid first-half revenue growth, meaningful gross margin expansion and strong improvement in operating profitability," said Steve Harshbarger, President and Chief Executive Officer.
The company reiterated its full fiscal year 2027 guidance for flat to modest revenue growth, citing the timing of several large orders.
Sono-Tek reported backlog of $9.51 million at August 31, 2026, up 23% from the prior quarter, and disclosed receiving three orders totaling approximately $7.19 million subsequent to quarter end that are expected to ship during fiscal 2028.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
MILTON, N.Y. -On Wednesday, Sono-Tek Corporation (NASDAQ:SOTK) reported second quarter fiscal 2027 results that fell short of analyst expectations, with both earnings and revenue missing consensus estimates as the company navigates the timing of large production system orders.
Shares of the precision ultrasonic coating systems manufacturer fell 14.47% in pre-market trading following the results.
The company posted adjusted earnings per share of $0.02, missing the analyst consensus of $0.04 by $0.02. Revenue for the quarter ended August 31, 2026, came in at $5.23 million, below the $5.56 million consensus estimate, though up 1% YoY from $5.16 million in the prior-year period.
Despite the quarterly miss, Sono-Tek reported strong performance in its medical sector, with sales surging 209% to $3.11 million in the second quarter, driven by shipments of balloon coating systems and specialty stent-coating systems.
For the first half of fiscal 2027, revenue increased 6% to $10.89 million, with medical market sales jumping 289% to $7.05 million.
Gross margin expanded to 53% in the second quarter from 50% in the prior-year period, reflecting what the company described as an unusually favorable product and geographic mix.
Operating income decreased 9% to $382,000, while net income declined 14% to $366,000, or $0.02 per diluted share, compared with $424,000, or $0.03 per diluted share, in the second quarter of fiscal 2026.
"Fiscal 2027 is progressing well, with solid first-half revenue growth, meaningful gross margin expansion and strong improvement in operating profitability," said Steve Harshbarger, President and Chief Executive Officer.
The company reiterated its full fiscal year 2027 guidance for flat to modest revenue growth, citing the timing of several large orders.
Sono-Tek reported backlog of $9.51 million at August 31, 2026, up 23% from the prior quarter, and disclosed receiving three orders totaling approximately $7.19 million subsequent to quarter end that are expected to ship during fiscal 2028.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
b3829680cf· 2026-10-14 19:16 · doubao / doubao-seed-evolving-latest-version · 策略包2226518bfdee当前